Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
Aethlon Medical reported a fiscal 2026 net loss of $7.2 million, a significant improvement from the $13.4 million loss in the prior year, driven by a 21.9% reduction in operating expenses to $7.3 million. The company ended the fiscal year with approximately $5.0 million in cash and subsequently raised $1.85 million in net proceeds through its at-the-market equity program, highlighting the need for capital preservation.
Key figures
- Revenue
- 0
- Atm proceeds
- 1850000
- Operating expenses
- 7293631
- Shares outstanding
- 1570449
- Cash and equivalents
- 5026458
- Operating expenses yoy change
- -21.9%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.